Geriatric Depression Scale
Geriatric Depression Scale
The Geriatric Depression Scale (GDS) is a psychological assessment tool designed to measure depression in older adults. The scale was first developed by J.A. Yesavage and colleagues in 1982, and has since been used extensively in both clinical and research settings.
Overview[edit | edit source]
The GDS is a self-report measure that consists of 30 items. Each item is a yes/no question related to the individual's feelings over the past week. The scale is specifically designed to avoid focusing on somatic symptoms, given that these can often be attributed to physical health problems common in older adults. Instead, the GDS focuses on cognitive and affective symptoms of depression.
Scoring and Interpretation[edit | edit source]
Scores on the GDS range from 0 to 30, with higher scores indicating greater levels of depressive symptoms. A score of 0-9 is considered normal, 10-19 indicates mild depression, and 20-30 indicates severe depression. It is important to note that the GDS is a screening tool and not a diagnostic tool. Therefore, a high score should be followed up with a comprehensive clinical assessment to confirm a diagnosis of depression.
Validity and Reliability[edit | edit source]
The GDS has been found to have good psychometric properties, including high internal consistency and good test-retest reliability. It has also been validated against other measures of depression, such as the Hamilton Depression Rating Scale.
Limitations[edit | edit source]
While the GDS is a valuable tool for identifying depression in older adults, it does have some limitations. For example, it may not be as effective in individuals with cognitive impairment or those with a high level of physical illness. Additionally, it does not assess for suicidal ideation, which is an important component of depression.
See Also[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD